Clinical trials
Recruiting trials in Brazil with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
307 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 10 |
| 2022 | 19 |
| 2023 | 28 |
| 2024 | 72 |
| 2025 | 83 |
| 2026 | 77 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 307 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo General Hospital | 31 |
| University of Sao Paulo | 29 |
| University of Nove de Julho | 21 |
| Hospital de Clinicas de Porto Alegre | 16 |
| Federal University of Minas Gerais | 11 |
| Brainfarma Industria Química e Farmacêutica S/A | 7 |
| Federal University of Health Science of Porto Alegre | 7 |
| Universidade Federal Fluminense | 7 |
| Federal University of Rio Grande do Sul | 6 |
| Instituto do Cancer do Estado de São Paulo | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 15 |
| Inflammation | 11 |
| Obesity | 10 |
| Stroke | 10 |
| Breast Neoplasms | 9 |
| Parkinson Disease | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Cardiovascular Diseases | 7 |
| Diabetes Mellitus | 7 |
| Heart Failure | 7 |
Trials
Showing 1 to 25 of 307. Each trial links to its page on Pharma Observatory.
207 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.